Reuters Asia Top

By Rina Chandran and Avi Asher-Schapiro BANGKOK/LOS ANGELES (Thomson Reuters Foundation) – A landmark lawsuit by Rohingya refugees against Meta Platforms Inc, formerly known as Facebook, is a “wake-up call” for social media firms and a test case for courts to limit their immunity, human rights and legal experts said. The $150 billion class-action complaint, …

Analysis-Rohingya lawsuit against Facebook a ‘wake-up call’ for social media Read More »

By Hyonhee Shin SEOUL (Reuters) – South Korea will further cut the interval for coronavirus booster vaccines for all adults from four to five months to three, officials said on Friday, as it struggles to fight record levels of infections amid concerns over the Omicron variant. The move came three weeks after the government reduced …

S.Korea to cut COVID-19 booster shot interval again as infections rise Read More »

SINGAPORE (Reuters) – AstraZeneca said on Friday it will supply Singapore with its COVID-19 antibody cocktail, Evusheld, by the end of the year. Evusheld can act as another layer of protection, alongside vaccines, for people who are at high risk of COVID-19 infection, according to AstraZeneca’s statement. The company did not specify how many courses …

AstraZeneca to supply COVID-19 antibody cocktail to Singapore Read More »

BEIJING (Reuters) – China administered about 7.8 million doses of COVID-19 vaccines on Dec 9, bringing the total number of doses administered to 2.583 billion, data from the National Health Commission showed on Friday. (Reporting by Beijing newsroom; Editing by Christopher Cushing)

LONDON (Reuters) – The Chinese embassy in London said an unofficial tribunal of lawyers which accused Beijing of genocide against the Uyghurs was nothing more than a political tool of China’s enemies which were spreading lies. The unofficial tribunal of lawyers and campaigners said on Thursday that Chinese President Xi Jinping bore primary responsibility for …

China says ‘Uyghur tribunal’ is a lie Read More »